Mottola Frank

Supernus Pharmaceuticals, Inc. · SVP

Mottola Frank is listed in filings as SVP at Supernus Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Mar 10, 2026, including sale activity. Recent filings connect the profile to Supernus Pharmaceuticals, Inc. (SUPN). The current snapshot covers public activity from Feb 24, 2025 to Mar 10, 2026. Reported amounts are shown as $87.1K to $49.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceLast Price
Supernus Pharmaceuticals, Inc.SUPN$757k15k sharesSellDec 19, 2025$50.47$46.64
Supernus Pharmaceuticals, Inc.SUPN$251k5k sharesSellDec 19, 2025$50.22$46.64
Supernus Pharmaceuticals, Inc.SUPN$229k5k sharesSellSep 12, 2025$45.87$46.64
Supernus Pharmaceuticals, Inc.SUPN$623k14k sharesSellAug 25, 2025$44.51$46.64